NASAL ADMINISTRATION - A TOOL FOR TOMORROWS SYSTEMIC ADMINISTRATION OF DRUGS

被引:22
作者
DUCHENE, D
PONCHEL, G
机构
[1] Laboratoire de Physico-chimie, Pharmacotechnie, Biopharmacie
[2] Faculté de Pharmacie, Université de Paris-Sud, 92290, Châtenay, Malabry, Rue Jean Baptiste Clément
关键词
D O I
10.3109/03639049309038763
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
By its anatomy and physiology, due to the great amount of air treated there, the nasal route represents a very interesting possibility for the administration of products degraded in the gastro-intestinal tract or inhibited by the first hepatic pass. The nasal dosage forms most studied are bioadhesive hydrogels and microspheres, especially for the systemic administration of peptides.
引用
收藏
页码:101 / 122
页数:22
相关论文
共 53 条
[31]  
MAITANI Y, 1991, INT J PHARM, V69, P21
[32]  
MAITANI Y, 1989, INT J PHARM, V49, P23
[33]   ANALYSIS OF STRUCTURAL REQUIREMENTS FOR THE ABSORPTION OF DRUGS AND MACROMOLECULES FROM THE NASAL CAVITY [J].
MCMARTIN, C ;
HUTCHINSON, LEF ;
HYDE, R ;
PETERS, GE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (07) :535-540
[34]   ABSORPTION ENHANCING EFFECT OF CYCLODEXTRINS ON INTRANASALLY ADMINISTERED INSULIN IN RATS [J].
MERKUS, FWHM ;
VERHOEF, JC ;
ROMEIJN, SG ;
SCHIPPER, NGM .
PHARMACEUTICAL RESEARCH, 1991, 8 (05) :588-592
[35]   EFFECTS OF PROTEOLYTIC-ENZYME INHIBITORS ON THE NASAL ABSORPTION OF VASOPRESSIN AND AN ANALOG [J].
MORIMOTO, K ;
YAMAGUCHI, H ;
IWAKURA, Y ;
MIYAZAKI, M ;
NAKATANI, E ;
IWAMOTO, T ;
OHASHI, Y ;
NAKAI, Y .
PHARMACEUTICAL RESEARCH, 1991, 8 (09) :1175-1179
[36]  
MORIMOTO K, 1986, J PHARM PHARMACOL, V37, P134
[37]  
MOSES AC, 1987, DIABETES ANN, V3, P107
[38]  
NAGAI T, 1985, PHARM INT, V6, P196
[39]   NASAL ABSORPTION ENHANCERS FOR BIOSYNTHETIC HUMAN GROWTH-HORMONE IN RATS [J].
OHAGAN, DT ;
CRITCHLEY, H ;
FARRAJ, NF ;
FISHER, AN ;
JOHANSEN, BR ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1990, 7 (07) :772-776
[40]  
PATAPOFF TW, 1990, P INT S CONTROL REL, V17, P462